Clinical trials
Observational Cardiomyopathies trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 9 |
| Unknown status | 8 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Bonn | 6 |
| Abbott Medical Devices | 2 |
| German Heart Institute | 2 |
| Heidelberg University | 2 |
| Johann Wolfgang Goethe University Hospital | 2 |
| University Hospital Heidelberg | 2 |
| University Hospital, Essen | 2 |
| University Medical Center Goettingen | 2 |
| University Medicine Greifswald | 2 |
| Alnylam Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 39 |
| Heart Failure | 15 |
| Cardiomyopathy, Dilated | 5 |
| Cardiovascular Diseases | 5 |
| Myocarditis | 5 |
| Heart Diseases | 4 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis | 3 |
| Cardiomyopathy, Hypertrophic | 3 |
| Coronary Artery Disease | 3 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.